Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and diet for treatment of metabolic syndrome
IRCT2013052013399N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in cardiometabolic risk (CMR) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Aug 2013; status: completed.
02
Drugs
metformin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT2013052013399N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013052013399N1.